AppLovin target lifted by $240 at Oppenheimer on non-gaming advertising growth

Audacy has teamed up with MOGL to create exciting NIL opportunities for college athletes, allowing them to be featured in advertising campaigns within Audacy's extensive sports portfolio. This partnership is significant as it opens new avenues for athletes to monetize their name, image, and likeness, enhancing their visibility and financial prospects in the sports industry.

Applovin Corp's stock has reached an all-time high of 657.66 USD, marking a significant milestone for the company and its investors. This surge reflects growing confidence in Applovin's business model and future prospects, making it a noteworthy event in the stock market. Investors are optimistic about the company's potential for continued growth, which could lead to further increases in stock value.

Analysts have raised their target price for Samsung's stock as the company's recent rally continues to gain momentum. This is significant because it reflects growing confidence in Samsung's performance and potential for future growth, which could attract more investors and boost the overall market.

Retail giants like Walmart and Target are struggling to keep pace with the frequent price changes driven by tariffs, leading them to remove price tags and eliminate discounts. This situation is significant as it highlights the challenges retailers face in managing costs and pricing strategies, ultimately affecting consumers who may see higher prices on everyday items.

Neurocrine Biosciences has received a boost as Jefferies has raised its stock price target to $169. This adjustment reflects growing confidence in the company's potential and could attract more investors. Such positive analyst ratings often lead to increased market interest, which is crucial for the company's growth and stability in the competitive biotech sector.

Baird has raised its price target for Alphabet's stock to $275, highlighting the company's strong position in the search market. This adjustment reflects confidence in Alphabet's ability to maintain its dominance and suggests potential for growth, which is encouraging for investors. As the digital landscape evolves, Alphabet's continued innovation and market leadership could lead to significant returns.

Recent data shows that Russians are significantly increasing their spending on foreign holidays, with Türkiye emerging as the top travel destination. This trend highlights a growing interest in international travel among Russians, which could have positive implications for the tourism industry and local economies in popular destinations.

The FDA's recent approval of a new drug for autism marks a significant shift in the review process for treatments targeting this condition. This decision not only opens doors for innovative therapies but also highlights the growing recognition of autism in the healthcare landscape. It matters because it could lead to improved quality of life for individuals with autism and their families, offering hope where there was previously limited options.

Auterion, a defense tech startup, has successfully raised $130 million in a Series B funding round, signaling strong investor confidence in its innovative drone software. This funding will enable Auterion to expand its technology for drone warfare, which is increasingly relevant in modern defense strategies. CEO Lorenz Meier discussed the implications of this funding on Bloomberg Tech, highlighting the potential for enhanced capabilities in military operations. This development is significant as it reflects the growing importance of advanced technology in defense and security.

FAT Brands is currently in discussions with advisers as it navigates restructuring talks with its bondholders. This development is significant as it highlights the company's efforts to manage its financial obligations and stabilize its operations. The outcome of these talks could impact the future of the brand and its ability to continue expanding in the competitive food industry.

In a fiery address at the United Nations General Assembly, President Donald Trump criticized the UN for not supporting his diplomatic initiatives, dismissing climate change as a hoax and labeling uncontrolled migration as the foremost political issue today. This speech highlights Trump's ongoing tension with international bodies and his controversial stance on global issues, which could impact future diplomatic relations and global cooperation.

Former President Donald Trump has stirred controversy by linking autism to the use of Tylenol and vaccines, a claim that lacks scientific backing. This assertion raises concerns as it may contribute to misinformation about autism and vaccine safety, potentially influencing public perception and health decisions. It's crucial to rely on credible scientific research when discussing such sensitive topics.